AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glucap-G1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Sycap Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glucap-G1 Tablet SR

Diabetic patients using Glycemic Control-G1 Extended-Release tablets, a dual-action antidiabetic medication, manage type 2 diabetes mellitus. This combination therapy regulates blood glucose. Administer this medication with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; abrupt cessation can elevate blood glucose, increasing risks of nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifested by sweating, dizziness, headache, and tremors. Consistent meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glucap-G1 Tablet SR

No text provided. Please provide the text you would like me to rephrase.

Uses of Glucap-G1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glucap-G1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glucap-G1 Tablet SR. Ingest the tablet whole; do not crush, chew, or break it before swallowing. Consume this medication with food.

Common Side effects of Glucap-G1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glucap-G1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glucap-G1 Tablet SR should be administered with a meal.

How Glucap-G1 Tablet SR works:

Glucap-G1 SR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glucap-G1 Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glucap-G1 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glucap-G1 tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glucap-G1 Tablet SR cautiously, potentially requiring dosage modification under medical supervision. Glucap-G1 Tablet SR is contraindicated in patients with severely compromised kidney function. Routine monitoring of renal function is recommended during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glucap-G1 SR tablets, as dose modification may be necessary. A physician's consultation is advised. For those with mild to moderate liver disease, Glucap-G1 SR tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glucap-G1 Tablet SR :

Should you forget a Glucap-G1 Tablet SR dose, take it immediately if you remember. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glucap-G1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Glucap-G1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glucap-G1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glucap-G1 Tablet SR and seek immediate medical attention.
Glucap-G1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glucap-G1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glucap-G1 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glucap-G1 SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glucap-G1 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glucap-G1 Tablet SR
48
MRP 56
13% off